Edwards Lifesciences Corporation (EW)
Company Info
ISIN | US28176E1082 |
---|---|
CUSIP | 28176E108 |
Sector | Healthcare |
Industry | Medical Devices |
Highlights
Market Cap | $57.52B |
---|---|
EPS | $2.30 |
PE Ratio | 41.55 |
PEG Ratio | 5.49 |
Revenue (TTM) | $6.00B |
Gross Profit (TTM) | $4.30B |
EBITDA (TTM) | $1.87B |
Year Range | $60.57 - $96.12 |
Target Price | $92.92 |
Short % | 1.75% |
Short Ratio | 2.57 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: EW vs. NVNO, EW vs. SYK, EW vs. BAX, EW vs. SPY, EW vs. IHI, EW vs. SCHG, EW vs. VOO, EW vs. MCK, EW vs. LLY, EW vs. DHR
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Edwards Lifesciences Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Edwards Lifesciences Corporation had a return of 13.38% year-to-date (YTD) and -0.06% in the last 12 months. Over the past 10 years, Edwards Lifesciences Corporation had an annualized return of 20.72%, outperforming the S&P 500 benchmark which had an annualized return of 10.37%.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 13.38% | 5.06% |
1 month | -8.33% | -3.23% |
6 months | 25.14% | 17.14% |
1 year | -0.06% | 20.62% |
5 years (annualized) | 7.92% | 11.54% |
10 years (annualized) | 20.72% | 10.37% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 2.91% | 8.16% | 12.60% | |||||||||
2023 | -9.40% | -8.03% | 6.26% | 12.61% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Edwards Lifesciences Corporation(EW)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Edwards Lifesciences Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Edwards Lifesciences Corporation was 52.78%, occurring on Oct 27, 2023. The portfolio has not yet recovered.
The current Edwards Lifesciences Corporation drawdown is 33.85%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-52.78% | Dec 31, 2021 | 459 | Oct 27, 2023 | — | — | — |
-50.48% | Sep 1, 2000 | 43 | Nov 1, 2000 | 165 | Jun 29, 2001 | 208 |
-44.02% | Oct 5, 2012 | 299 | Dec 13, 2013 | 217 | Oct 24, 2014 | 516 |
-37.11% | Feb 12, 2002 | 112 | Jul 23, 2002 | 199 | May 7, 2003 | 311 |
-36.15% | Nov 29, 2019 | 78 | Mar 23, 2020 | 110 | Aug 27, 2020 | 188 |
Volatility
Volatility Chart
The current Edwards Lifesciences Corporation volatility is 6.06%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |